chrX-100650802-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_014467.3(SRPX2):c.100G>A(p.Asp34Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000744 in 1,208,969 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_014467.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SRPX2 | NM_014467.3 | c.100G>A | p.Asp34Asn | missense_variant | 3/11 | ENST00000373004.5 | NP_055282.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SRPX2 | ENST00000373004.5 | c.100G>A | p.Asp34Asn | missense_variant | 3/11 | 1 | NM_014467.3 | ENSP00000362095.3 |
Frequencies
GnomAD3 genomes AF: 0.0000179 AC: 2AN: 111626Hom.: 0 Cov.: 22 AF XY: 0.0000296 AC XY: 1AN XY: 33800
GnomAD3 exomes AF: 0.0000164 AC: 3AN: 183246Hom.: 0 AF XY: 0.0000443 AC XY: 3AN XY: 67690
GnomAD4 exome AF: 0.00000638 AC: 7AN: 1097343Hom.: 0 Cov.: 29 AF XY: 0.0000110 AC XY: 4AN XY: 362719
GnomAD4 genome AF: 0.0000179 AC: 2AN: 111626Hom.: 0 Cov.: 22 AF XY: 0.0000296 AC XY: 1AN XY: 33800
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 06, 2024 | The c.100G>A (p.D34N) alteration is located in exon 3 (coding exon 2) of the SRPX2 gene. This alteration results from a G to A substitution at nucleotide position 100, causing the aspartic acid (D) at amino acid position 34 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at